Video: MagicMed CEO Dr. Joseph Tucker Presenting at Psychedelics Capital Sept 2020

Joseph Tucker, Chief Executive Officer, MagicMed Industries Inc. gave presentation at the Psychedelic Capital Sept 3rd- The gold standard for psychedelic investment. MagicMed Industries intends to partner with pharmaceutical and other companies to develop psychedelic-derived medicinal and licit consumer goods products.

MagicMed’s molecular derivatives library, the Psybrary™ is anticipated to be an essential building block from which industry can develop new patented products. The initial focus of the Psybrary™ is on psilocybin, and is expected to be opportunistically expanded to other psychedelics like MDMA, ketamine, ibogaine, mescaline, and ayahuasca. Joseph Tucker Chief Executive Officer, MagicMed Industries Inc.

Primary Sponsor


Karma Koala Podcast

Top Marijuana Blog